78
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Increased tissue factor, MMP-8, and D-dimer expression in diabetic patients with unstable advanced carotid atherosclerosis

, , , , , , , & show all
Pages 405-412 | Published online: 24 Dec 2022

References

  • BaughMDGavrivolicJDaviesIRMonocyte matrix metalloproteinase production in type 2 diabetes and controls—a cross sectional studyCardiovasc Diabetol20032312672267
  • BladinCFAlexandrofAVMurphyJCarotid stenosis index. A new method of measuring internal carotid artery stenosisStroke19952623047831693
  • BuchsAEKornbergAZahaviMIncreased expression of tissue factor and receptor for advanced Glycation end products in peripheral blood mononuclear cells of patients with type 2 diabetes mellitus with vascular complicationsExp Diabesity Res20045163915203887
  • CipolloneFIezziAFaziaMThe receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human therosclerotic plaques: role of glycemic controlCirculation20031081070712912808
  • CipolloneFPronteraCPiniBOverexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E(2)-dependent plaque instabilityCirculation2001104921711514380
  • CuccurulloCIezziAFaziaMLSuppression of RAGE as a basis of simvastatin-dependent plaque stabilization in type 2 diabetesArterioscler Thromb Vasc Biol20062627162317038636
  • CorradoERizzoMMuratoriIAssociation of elevated fibrinogen and C-reactive protein levels with carotid lesions in patients with newly diagonosed hypertension or type II diabetesArch Med Res2006371004917045118
  • CortiRHutterRBadimonJJEvolving concepts in the triad of atherosclerosis, inflammation and thrombosisThromb Thrombolysis2004173544
  • CunninghamACHastyKAEnghildJJStructural and functional characterization of tissue factor pathway inhibitor following degradation by matrix metalloproteinase-8Biochem J2002367451812117418
  • DeathAKFisherEJMcGrathKCHigh glucose alters matrix metalloproteinase expression in two key vascular cells: potential impact on atherosclerosis in diabetesAtherosclerosis200316826326912801609
  • DerosaGD’AngeloATinelliCEvaluation of metalloproteinase 2 and 9 levels and their inhibitors in diabetic and healthy subjectsDiabetes Metab2007 Epub ahead of print
  • DiamantMNieuwlandRPabloRFElevated numbers of tissue-factor exposing microparticles correlate with components of the metabolic syndrome in uncomplicated type 2 diabetes mellitusCirculation20021062442712417540
  • Gray-WealeACGrahamJCBurnettJRCarotid artery atheroma: comparison of preoperative B-mode ultrasound appearance with carotid endarterectomy specimen pathologyCardiovasc Surg19882967681
  • HaffnerSMLipoprotein disorders associated with type 2 diabetes mellitus and insulin resistanceAm J Cardiol20029055i61i
  • HoFMLiuSHLinWWOpposite effects of high glucose on MMP-2 and TIMP-2 in human endothelial cellsJ Cell Biochem2007 Epub ahead of print
  • JanderSSitzerMWendtAExpression of tissue factor in high-grade carotid artery stenosis: association with plaque destabilizationStroke200132850411283381
  • KingHAubertREHermanWHGlobal burden of diabetes, 1995–2025, prevalence, numerical estimates, and projectionsDiabetes Care1998211414319727886
  • KonieczkowskiMSkrinskaVAIncreased synthesis of thromboxane A(2) and expression of procoagulant activity by monocytes in response to arachidonic acid in diabetes mellitusProstaglandins Leukot Essent Fatty Acids200165133811728163
  • KrupinskiJMiguel TuruMEndogenous expression of C-reactive protein is increased in active (ulcerated non-complicated) human carotid artery plaquesStroke2006371200416601222
  • KrupinskiJCatenaEMiguelMD-dimer local expression is increased in symptomatic patients undergoing carotid endarterectomyInt J Cardiol2007116174916901564
  • KrupinskiJTuruMSlevinMCarotid plaque, pathogenesis of stroke, and CRP: Implications for treatment of ischemic stroke, hemorrhagic transformationCurr Treat Opt Cardiovasc Med2007922935
  • LeursPBStolkRPHamulyakKTissue factor pathway inhibitor and other endothelium-dependent hemostatic factors in elderly individuals with normal or impaired glucose tolerance and type 2 diabetesDiabetes Care2002251340512145232
  • LipinskiBPathophysiology of oxidative stress in diabetes mellitusDiabetes Complicat20011520310
  • MeeraraniPMorenoPRCimminoGAtherothrombosis: role of tissue factor; link between diabetes, obesity and inflammationIndian J Exp Biol2007451031017249334
  • MorelOTotiFHugelBProcoagulant microparticles: disrupting the vascular homeostasis equation?Arterioscler Thromb Vasc Biol200626259460416990554
  • [NASCET] North American Symptomatic Carotid Endarterectomy Trial CollaboratorsBeneficial effect of carotid endarterectomy in symptomatic patients with high grade carotid stenosisN Eng J Med199132544553
  • PaolettiRBolegoCPoliAMetabolic syndrome, inflammation and atherosclerosisVasc Health Risk Manag200621455217319458
  • RubioFMartinez-YelamosSCadonaPCarotid endarterectomy: Is it still the gold standard?Cerebrovasc Dis2005201192216327261
  • SambolaAOsendeJHathcockJRole of risk factors in the modulation of tissue factor activity and blood thrombogenicityCirculation2003107973712600909
  • ShahPKThrombogenic risk factors for atherothrombosisRev Cardiovasc Med20067101616534491
  • SlevinMGaffneyJKumarSAngiogenic oligosaccharides of hyaluronan induce multiple signaling pathways impacting vascular endothelial cell mitogenesis and wound healingJ Biol Chem2002277410465912194965
  • SommeijerDWHansenHRVan OerleRSoluble tissue factor is a candidate marker for progression of microvascular disease in patients with type 2 diabetesJ Thromb Haemost200645748016371118
  • StaryHCBleakley-ChandlerADinsmoreREA definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosisCirculation1995921355747648691
  • SteffelJLuscherTFTannerFCTissue factor in cardiovascular diseases: molecular mechanisms and clinical applicationsCirculation20061137223116461845
  • TkacISalagovicJKozarovaMAngiotensin-converting enzyme genotype, albuminuria and plasma fibrinogen in type 2 diabetes mellitusWien Klin Wochenschr2003115835914740347
  • TuruMMKrupinskiJMontanerJMatrix metalloproteinases in plaque and plasma from patients with advanced carotid atherosclerosisAtherosclerosis2006187161916259988
  • VambergueARugeriLGaveriauxVFactor VII, tissue factor pathway inhibitor, and monocyte tissue factor in diabetes mellitus: Influence of type of diabetes, obesity index, and ageThromb Res20011013677511297753
  • VaidyulaVRRaoAKMozzoliMEffects of hyperglycaemia and hyperinsulinaemia on circulating tissue factor procoagulant activity and platelet CD40 ligandDiabetes200655202816380494
  • Viles-GonzalezJFFusterVBadimonJJLinks between inflammation and thrombogenicity in atherosclerosisCurr Mol Med200664899916918370
  • WallSJSampsonMJLevellNElevated matrix metalloproteinase-2 and-3 production from human diabetic dermal fibroblastsBr J Dermatol2003149131612890189